Parkhurst NuVision
Parkhurst NuVision is a San Antonio-based refractive and cataract surgery practice offering all 10 modern vision correction procedures — the most experienced EVO ICL center in the U.S. (10,000+ procedures) — serving adult patients across LASIK, presbyopia, and cataract segments as a subsidiary of NVISION®.
- Company typePrivate
- Founded2013
- HeadquartersSan Antonio, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Parkhurst NuVision does
Parkhurst NuVision is a privately held refractive and cataract surgery practice headquartered in San Antonio, Texas, with a satellite location in New Braunfels. Founded in 2013 by Dr. Gregory Parkhurst (MD, FACS), the practice operates as a subsidiary of NVISION® (legally Laser Eye Care of California, LLC) and serves adult patients across three core segments: adults 18–45 seeking laser vision correction (LASIK, SMILE, PRK, EVO ICL), adults 40+ with presbyopia, and adults 60+ with cataracts. The practice is the most experienced EVO ICL center in the United States, with 10,000+ ICL procedures performed and 25,000+ lifetime patients served. The clinical team includes ten doctors supported by an optometry, oculoplastic surgery, and refractive/cataract specialty bench with over 79 years of combined experience.
The practice's technology stack centers on advanced laser vision correction platforms (excimer and femtosecond lasers), the FDA-approved MS-39 Anterior Segment OCT for diagnostic imaging, and proprietary AI models — VAULT AI (Journal of Cataract & Refractive Surgery, 2024) and VAULT-OCT AI (Clinical Ophthalmology, 2025) — for ICL vault prediction. Parkhurst NuVision participates in FDA clinical trials and was the first U.S. site to perform Visian Toric ICL surgery (2018, with STAAR Surgical). Service line spans all 10 modern vision correction procedures, premium intraocular lens options (Light Adjustable Lens, PanOptix, Synergy, IC-8), and ancillary offerings including glaucoma, dry eye, keratoconus, and oculoplastic/cosmetic services.
Revenue is generated per surgical procedure on a one-time payment model, with LASIK priced at $2,000–$3,000 per eye and EVO ICL on a quote basis; financing is offered through CareCredit, Alphaeon, and T.H.S. plus zero-interest in-house plans, with FSA/HSA eligibility. Go-to-market combines direct-to-consumer digital marketing (SEO, social media across Facebook, Instagram, TikTok, YouTube, and Twitter), celebrity endorsements (notably George Strait), patient testimonial content, and a collaborative-care referral network with hundreds of independent optometric physicians nationwide. Telemedicine consultations extend reach to out-of-town patients, and pricing aids (LASIK savings calculator, self-test, cost guide) support online conversion.
Parkhurst NuVision firmographics
Firmographics- Name
- Parkhurst NuVision
- Legal name
- Laser Eye Care of California, LLC
- Website
- https://sanantonio-lasik.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Parkhurst NuVision is a San Antonio-based refractive and cataract surgery practice offering all 10 modern vision correction procedures — the most experienced EVO ICL center in the U.S. (10,000+ procedures) — serving adult patients across LASIK, presbyopia, and cataract segments as a subsidiary of NVISION®.
- Ownership category
- akta.pro rank
Parkhurst NuVision industry classification
Industry- Product category
- Refractive and Cataract Surgery Services
- NAICS
- Offices of Optometrists (621320), Offices of Optometrists (62132)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF)
- akta.pro secondary industries
- Optometry Clinics (Primary Eye Care) (HLAKAKAB), Comprehensive Eye Exams & Vision Care (HLAKAKAA)
Keywords
Where Parkhurst NuVision is headquartered
LocationHeadquarters
- HQ city
- San Antonio
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Parkhurst NuVision business model
Business model- GTM type
- B2C
- Offering type
- Services
Revenue model
- Vision Correction Surgical Procedures: One-time surgical procedures for vision correction including LASIK, EVO ICL, PRK, SMILE LASIK, refractive lens exchange, and cataract surgery. Pricing varies by procedure type and customization level. All-inclusive packages covering pre-operative care, the procedure, post-operative care, and medications.
- Financing and Payment Plans: Offers financing options including zero-interest payment plans and fixed monthly payments to make procedures more affordable. Partners with CareCredit, Alphaeon, and T.H.S. for healthcare financing.
- Cosmetic Procedures: BOTOX, Juvederm, laser/chemical peels, eyelid surgery, brow lifts, and other oculoplastic procedures offered through Parkhurst Med Spa.
- Diagnostic and Consultation Services: Vision evaluations, consultations, and diagnostic imaging services as part of the surgical care pathway.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | LASIK Eye Surgery - Standard |
| One time/ perpetual license | Pay-as-you-go | LASIK with Astigmatism Correction |
| Hybrid | Monthly | Financing Options |
| One time/ perpetual license | Pay-as-you-go | EVO ICL Surgery |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels10 records
Parkhurst NuVision product offering
Product offeringCore offering
Parkhurst NuVision is a physician-owned ophthalmology practice offering comprehensive vision correction procedures including LASIK, SMILE LASIK, PRK, EVO ICL, refractive lens exchange, custom laser cataract surgery, and presbyopia treatments. The practice provides diagnostics, surgical procedures, and post-operative care through two Texas clinic locations and virtual consultations, supported by collaborative care with nationwide optometric physicians.
Product overview
Parkhurst NuVision is a specialized vision correction practice offering a comprehensive portfolio of surgical and non-surgical eye care procedures. The core offering centers on 10 modern vision correction procedures including LASIK, SMILE LASIK, PRK, EVO ICL, and Refractive Lens Exchange, supplemented by Custom Laser Cataract Surgery with multiple IOL options (Light Adjustable Lens, PanOptix Trifocal, Synergy, IC-8). The practice also provides presbyopia solutions including VUITY eye drops and Corneal Inlay, along with medical services for glaucoma, dry eye, keratoconus, and cosmetic procedures. All services are supported by diagnostic technology including the MS-39 Anterior Segment OCT, online self-assessment tools, savings calculators, and telemedicine consultation options. The practice operates two locations in San Antonio and New Braunfels, Texas.
Differentiator
Problem solved
Functional benefit
Products and services
- LASIK Eye Surgery Laser-assisted in situ keratomileusis procedure that reshapes the cornea to correct nearsightedness, farsightedness, and astigmatism. Priced $2,000–$3,000 per eye with all-inclusive packages covering pre-op, procedure, post-op, and medications.
- SMILE LASIK Minimally invasive form of laser vision correction that removes a small lenticule through a tiny incision, FDA-approved in 2016 for treating nearsightedness.
- PRK (Photorefractive Keratectomy) Laser eye surgery that reshapes the cornea using an excimer laser to correct refractive errors, FDA-approved in 1995 and offered for patients who are not LASIK candidates.
- EVO ICL (Implantable Collamer Lens) Permanent contact lens surgically placed inside the eye to correct nearsightedness and astigmatism. Parkhurst NuVision is the most experienced EVO ICL practice in the United States with over 10,000 procedures performed.
- Refractive Lens Exchange (RLE) Lens replacement surgery that replaces the eye's natural lens with an artificial intraocular lens (IOL) to correct refractive errors and provide clear vision at all distances.
- Custom Laser Cataract Surgery Blade-free cataract removal procedure using laser technology to replace the clouded natural lens with a clear artificial intraocular lens, including premium lens options such as Light Adjustable, PanOptix Trifocal, Synergy, and IC-8 IOLs.
- Intraocular Lens (IOL) Options Multiple lens implant options including monofocal, multifocal, trifocal, and light adjustable lenses to customize vision correction following cataract or lens replacement surgery.
- VUITY Presbyopia-Correcting Eye Drops FDA-approved prescription eye drops for treating presbyopia (age-related blurry near vision) as a non-surgical alternative for patients seeking near vision improvement.
- Corneal Inlay (KAMRA) Small corneal implant designed to improve near vision by creating a pinhole effect, helping patients reduce their need for reading glasses.
- Glaucoma Treatment Medical and surgical treatments for glaucoma including the iDose travoprost implant for sustained drug delivery.
- Dry Eye Treatment Diagnostic and therapeutic services for managing dry eye syndrome including thermal pulsation and other treatments.
- Corneal Cross Linking Treatment for keratoconus that strengthens the cornea using riboflavin drops and UV light to halt progressive corneal thinning.
- Cosmetic & Oculoplastic Procedures Oculoplastic surgical services including eyelid surgery (blepharoplasty), brow lifts, ptosis treatment, laser/chemical peels, BOTOX, and Juvederm injectables performed by an oculoplastic surgeon.
- Virtual Consultation Telemedicine consultation service enabling remote vision correction evaluations and initial assessments for prospective patients.
Quantifiable outcome
- 25,000+ patients helped achieve clear vision
- +3 more outcomes
Companies that use Parkhurst NuVision
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles4 records
Parkhurst NuVision technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Parkhurst NuVision partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- NVISION CenterscoreNVISION expands its ophthalmology clinical trial site network in collaboration with Parkhurst NuVision. BusinessWire announcement June 2024. Parkhurst NuVision operates as part of NVISION/NVISION Centers network.
- Himalayan Cataract ProjectcoreFor every refractive treatment performed at Parkhurst NuVision, they donate a sight-saving procedure to underserved communities around the world through the Himalayan Cataract Project. This mission-driven partnership helps cure blindness in developing countries.
- Visual Freedom FoundationcoreDr. Parkhurst serves as Chairman of the Board of the Visual Freedom Foundation. Foundation focuses on providing vision correction access and education.
- STAAR Surgical CompanycoreParkhurst NuVision was one of two U.S. sites (along with Brinton Vision in St. Louis) to perform first patient implants of Visian Toric ICLs in the U.S. in 2018. First U.S. Toric ICL surgery performed at facility.
- SEE InternationalcoreDr. Parkhurst travels annually with SEE International to provide ophthalmic care and cataract surgery to patients who otherwise could not afford treatment in developing countries including Mexico and El Salvador.
- UIW Rosenberg School of OptometryminorClinical Experience Partner for optometry students. Parkhurst NuVision serves as clinical training site for optometry residents and students.
- Refractive Surgery Alliance (RSA)coreDr. Parkhurst is a Founding Member and former President (2014) of RSA. Organization advances refractive surgery through education and advocacy.
- AECOS (American-European Congress of Ophthalmic Surgery)minorDr. Parkhurst is a Founding Member of AECOS, a professional organization for ophthalmic surgeons.
- Refractive FoundationscoreDr. Parkhurst serves as Director and Founder & Chair of World Council of Refractive Surgery Fellowships. Co-Producer of EVO ICL Workshop.
Scale indicators6 records
Recent moves7 records
Parkhurst NuVision competitors and assessment
Company assessmentBroad incumbents
- NVISION Eye Centers: National ophthalmology network and parent operating entity of Parkhurst NuVision (legal: Laser Eye Care of California, LLC). Operates multiple LASIK/cataract clinics across the U.S. and runs the clinical-trial network Parkhurst participates in; comparable as a multi-site refractive and cataract surgery provider.
Direct peers
- Mann Eye Institute: Texas-based ophthalmology practice offering LASIK, cataract surgery with premium IOLs, and other refractive procedures. Directly comparable as a regional, multi-location refractive/cataract practice in the same Sun Belt geography.
- LasikPlus: Large national LASIK-focused chain with dozens of U.S. centers. Directly comparable as a high-volume, branded refractive surgery provider competing in LASIK pricing and consumer marketing.
- TLC Laser Eye Centers: Long-established North American LASIK and refractive surgery chain. Comparable as a multi-site branded provider of laser vision correction targeting similar consumer demographics.
- Brinton Vision: St. Louis-based refractive surgery practice and one of only two U.S. sites (with Parkhurst) to perform the first Visian Toric ICL implants. Closely comparable in EVO/Toric ICL specialization and premium refractive positioning.
- Key-Whitman Eye Center: Dallas-based multi-specialty ophthalmology practice offering LASIK, cataract surgery with premium IOLs, and other vision correction. Comparable as a Texas regional refractive and cataract competitor.
- The LASIK Vision Institute: National value-oriented LASIK provider with many U.S. centers. Comparable as a direct competitor in mass-market laser vision correction, particularly on price-sensitive patients.
- Dello Russo Laser Vision: Northeast U.S. refractive surgery practice offering LASIK, PRK, and other laser vision correction. Comparable as a single-region branded refractive provider with celebrity/athlete patient marketing.
Others
- STAAR Surgical: Manufacturer of the EVO ICL/EVO+ ICL Implantable Collamer Lens that Parkhurst implants. Comparable as the supplier of Parkhurst's flagship procedure and a strategic technology partner.
- Carl Zeiss Meditec: Ophthalmic device manufacturer supplying diagnostic and laser platforms used by Parkhurst (including the telemedicine partnership for LASIK/cataract screening). Comparable as a key enabling technology vendor for Parkhurst's refractive and cataract procedures.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Parkhurst NuVision social profiles
Digital presenceParkhurst NuVision financial estimates
Financial estimateRevenue estimate
Valuation estimate
Parkhurst NuVision leadership team
Management profileNumber of profiles
Profiles8 records
Parkhurst NuVision funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Parkhurst NuVision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Parkhurst NuVision
What does Parkhurst NuVision do?
Parkhurst NuVision is a physician-owned ophthalmology practice offering comprehensive vision correction procedures including LASIK, SMILE LASIK, PRK, EVO ICL, refractive lens exchange, custom laser cataract surgery, and presbyopia treatments. The practice provides diagnostics, surgical procedures, and post-operative care through two Texas clinic locations and virtual consultations, supported by collaborative care with nationwide optometric physicians.
Is Parkhurst NuVision a public or private company?
Parkhurst NuVision is a private company. It is classified as corporate owned and is currently operating.
When was Parkhurst NuVision founded?
Parkhurst NuVision was founded in 2013. It employs 101 to 250 people.
Where is Parkhurst NuVision based?
Parkhurst NuVision is headquartered in San Antonio, United States, in the North America region.
How does Parkhurst NuVision make money?
Four revenue lines are on record. Vision Correction Surgical Procedures are the primary driver. The others are financing and Payment Plans, cosmetic Procedures and diagnostic and Consultation Services.
Who are Parkhurst NuVision's main competitors?
NVISION Eye Centers is listed as a broad incumbent. Direct peers are Mann Eye Institute, LasikPlus, TLC Laser Eye Centers, Brinton Vision, Key-Whitman Eye Center, The LASIK Vision Institute and Dello Russo Laser Vision. Others are STAAR Surgical and Carl Zeiss Meditec.
Does Parkhurst NuVision have an API?
No public API is recorded for Parkhurst NuVision.
What industry is Parkhurst NuVision in?
Parkhurst NuVision's product category is Refractive and Cataract Surgery Services. Its primary akta.pro industry code is HLAKAKAF, Cornea, External Disease & Refractive Surgery (LASIK/PRK), with a secondary code of HLAKAKAB, Optometry Clinics (Primary Eye Care). Its NAICS code is 621320 and its SIC code is 8011.